CIEPLINSKA AGNIESZKA (VP FINANCE, CONTROLLER (PAO)) sold 22.6% of their position (921.00 shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $27.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/14/2020ACC: 0001179110-20-004869
Officer· VP FINANCE, CONTROLLER (PAO)
Since Jan 2020
+5.38K
Net shares
Net buyer
$27.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.30K acquired · 921.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.15K
Price / share
—
Trade value
—
% of position
338.0%
4/12/2020
932.00→4.08K
Common Stock
Direct
Shares
−921.00
Price / share
$29.57
Trade value
$27.23K
% of position
22.6%
4/14/2020
4.08K→3.16K
Total
Net shares
+2.23K
Net value
-$27.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/12/2020 | A · Award | +3.15K | — | — | 338.0% | 932.00 | 4.08K |
| Common Stock Direct | 4/14/2020 | S · Sale | −921.00 | $29.57 | $27.23K | 22.6% | 4.08K | 3.16K |
| Total | +2.23K | -$27.23K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.15K shares
Shares
+3.15K
Strike price
Held after
3.15K
Exercisable
—
4/12/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.15K shares | 4/12/2020 | A · Award | +3.15K | — | 3.15K |